Champions Oncology Inc CSBR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.84
- Day Range
- $5.97–6.13
- 52-Week Range
- $5.50–8.74
- Bid/Ask
- $6.10 / $7.25
- Shares Outstanding
- 13.89M
- Market Cap
- $85.13M
- Volume/Avg
- 11,855 / 8,894
Key Statistics
- Price/Earnings (Normalized)
- 111.33
- Price/Sales
- 1.48
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 306
Valuation
|
Metric
|
CSBR
|
|---|---|
Price/Earnings (Normalized) | 111.33 |
Price/Book Value | 19.88 |
Price/Sales | 1.48 |
Price/Cash Flow | 51.19 |
Price/Earnings
CSBR
Financial Strength
|
Metric
|
CSBR
|
|---|---|
Quick Ratio | 0.93 |
Current Ratio | 0.98 |
Interest Coverage | — |
Quick Ratio
CSBR
Profitability
|
Metric
|
CSBR
|
|---|---|
Return on Assets (Normalized) | −3.16% |
Return on Equity (Normalized) | −22.67% |
Return on Invested Capital (Normalized) | −9.64% |
Return on Assets
CSBR
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|K>@>%^ | LOCK|!Jbg | $123B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|#y%%>< | LOCK|^cZhR | $71B | |||
| argenx SE ADR
ARGX
| LOCK|Ys@VDC | LOCK|Wg | $54B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|^T@Vc@g | LOCK|$&M | $36B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|bVZ#$<h | LOCK|s$Q$ | $36B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|?&^^>fbk | LOCK|vld> | $26B | |||
| Moderna Inc
MRNA
| LOCK|LY>&@#P | LOCK|Kv | $25B | |||
| Incyte Corp
INCY
| LOCK|wzXFkmy | LOCK|gy | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|^@w<^&c | LOCK|kS | $23B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|@?Hgt! | LOCK|K@ | $16B |
United States